These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3039052)

  • 21. Treatment of HIV-related cytomegalovirus disease of the gastrointestinal tract with foscarnet.
    Blanshard C
    J Acquir Immune Defic Syndr (1988); 1992; 5 Suppl 1():S25-8. PubMed ID: 1318364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis.
    Farese RV; Schambelan M; Hollander H; Stringari S; Jacobson MA
    Ann Intern Med; 1990 Jun; 112(12):955-6. PubMed ID: 2160217
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical experiences with phosphonoformate (foscarnet) treatment of viral diseases following renal transplantation.
    Ahlmén J; Wijnween AC; Brynger H; Lycke E
    Scand J Urol Nephrol Suppl; 1985; 92():41-4. PubMed ID: 3008316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS.
    Palestine AG; Polis MA; De Smet MD; Baird BF; Falloon J; Kovacs JA; Davey RT; Zurlo JJ; Zunich KM; Davis M
    Ann Intern Med; 1991 Nov; 115(9):665-73. PubMed ID: 1656826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Foscarnet for CMV retinitis.
    Wood CA
    Lancet; 1992 Feb; 339(8791):501. PubMed ID: 1346861
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cytomegalovirus pneumonia in patients with AIDS treated foscarnet. Our experience].
    Terra L; Pellicanò S; Calzone R; Mandica D; Milano M
    Minerva Med; 1997 Oct; 88(10):411-3. PubMed ID: 9417536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of a randomized controlled trial of foscarnet in patients with cytomegalovirus retinitis associated with acquired immunodeficiency syndrome.
    Polis MA
    Am J Med; 1992 Feb; 92(2A):22S-25S. PubMed ID: 1310572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foscarnet for cytomegalovirus infections.
    Ringdén O; Wilczek H; Lönnqvist B; Gahrton G; Wahren B; Lernestedt JO
    Lancet; 1985 Jun; 1(8444):1503-4. PubMed ID: 2861426
    [No Abstract]   [Full Text] [Related]  

  • 29. Successful treatment with trisodium phosphonoformate for primary cytomegalovirus infection after heart transplantation.
    Locke TJ; Odom NJ; Tapson JS; Freeman R; McGregor CG
    J Heart Transplant; 1987; 6(2):120-2. PubMed ID: 3040944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Foscarnet approved for cytomegalovirus retinitis.
    Am Fam Physician; 1991 Nov; 44(5):1890. PubMed ID: 1659165
    [No Abstract]   [Full Text] [Related]  

  • 31. Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens.
    Katlama C; Dohin E; Caumes E; Cochereau-Massin I; Brancon C; Robinet M; Rogeaux O; Dahan R; Gentilini M
    J Acquir Immune Defic Syndr (1988); 1992; 5 Suppl 1():S18-24. PubMed ID: 1318363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Didanosine and foscarnet marketed for use by patients with AIDS.
    Clin Pharm; 1992 Jan; 11(1):4, 6. PubMed ID: 1309689
    [No Abstract]   [Full Text] [Related]  

  • 33. Foscarnet sodium.
    Minor JR; Baltz JK
    DICP; 1991 Jan; 25(1):41-7. PubMed ID: 1848959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Foscarnet versus ganciclovir in the management of cytomegalovirus disease in patients with AIDS.
    Minor JR
    Am J Hosp Pharm; 1991 Nov; 48(11):2478-9. PubMed ID: 1660675
    [No Abstract]   [Full Text] [Related]  

  • 35. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA; Drew WL; Feinberg J; O'Donnell JJ; Whitmore PV; Miner RD; Parenti D
    J Infect Dis; 1991 Jun; 163(6):1348-51. PubMed ID: 1645385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Regressive diffuse leukoencephalitis under foscarnet in an AIDS infected patient].
    Nicoli F; Dhiver C; Chave B; Poizot-Martin I; Gastaut JA; Gastaut JL
    Presse Med; 1992 Mar; 21(9):436. PubMed ID: 1314379
    [No Abstract]   [Full Text] [Related]  

  • 37. Herpes simplex virus infection during foscarnet therapy.
    Cotte L; Langlois M; Trepo C
    J Infect Dis; 1992 Aug; 166(2):447-8. PubMed ID: 1321865
    [No Abstract]   [Full Text] [Related]  

  • 38. Foscarnet therapy of ganciclovir-resistant cytomegalovirus in marrow transplantation.
    Drobyski WR; Knox KK; Carrigan DR; Ash RC
    Transplantation; 1991 Jul; 52(1):155-7. PubMed ID: 1650043
    [No Abstract]   [Full Text] [Related]  

  • 39. Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients.
    Aschan J; Ringdén O; Ljungman P; Lönnqvist B; Ohlman S
    Scand J Infect Dis; 1992; 24(2):143-50. PubMed ID: 1322557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus and AIDS.
    Evans JK; Scoular A; Miller RF
    Genitourin Med; 1992 Feb; 68(1):60-1. PubMed ID: 1312508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.